Table 2 Genotype distribution of NoV positive samples among children with AGE in Tianjin from 2018 to 2020
Gentype | Number (n, %) | Total Number (n, %) | |
|---|---|---|---|
2018 ~ 2019 | 2019 ~ 2020 | ||
RdRp | |||
GII.P12 | 135 (34.1) | 2 (1.4) | 137 (25.4) |
GII.P15 | 1 (0.3) | 0 | 1 (0.2) |
GII.P16 | 5 (1.3) | 7 (4.9) | 12 (2.2) |
GII.P17 | 6 (1.5) | 0 | 6 (1.1) |
GII.P7 | 1 (0.3) | 1 (0.7) | 2 (0.4) |
GII.Pe | 248 (62.6) | 133 (93.0) | 381 (70.7) |
Capsid | |||
GII.1 | 6 (1.6) | 0 | 6 (1.2) |
GII.13 | 1 (0.3) | 0 | 1 (0.2) |
GII.17 | 5 (1.3) | 0 | 5 (1) |
GII.2 | 17 (4.5) | 10 (7.2) | 27 (5.2) |
GII.3 | 137 (36.1) | 2 (1.4) | 139 (26.8) |
GII.6 | 2 (0.5) | 0 | 2 (0.4) |
GII.4 Sydney 2012 | 211 (55.7) | 127 (91.4) | 338 (65.3) |
RdRp/Capsid | |||
GII.Pe-GII.4 Sydney 2012 | 190 (56.9) | 104 (90.4) | 294 (65.5) |
GII.P12-GII.3 | 120 (35.9) | 2 (1.7) | 122 (27.2) |
GII.P16-GII.2 | 4 (1.2) | 4 (3.5) | 8 (1.8) |
GII.P12-GII.2 | 1 (0.3) | 0 | 1 (0.2) |
GII.Pe-GII.3 | 8 (2.4) | 0 | 8 (1.8) |
GII.Pe-GII.2 | 3 (0.9) | 2 (1.7) | 5 (1.1) |
GII.Pe-GII.1 | 2 (0.6) | 0 | 2 (0.4) |
GII.P17-GII.17 | 5 (1.5) | 0 | 5 (1.1) |
GII.P7-GII.6 | 1 (0.3) | 0 | 1 (0.2) |
GII.P16-GII.4 Sydney 2012 | 0 | 3 (2.6) | 3 (0.7) |